Tapewire

NYSE · USD

MRK

Merck & Co., Inc.

Export transactions ↓
Tapewire entity
2807
SEC CIK
0000310158
Parsed reports
1,951

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 2026016
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026017
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
Schechter Adam HEVP & Pres-Global Human Health
Exercise / conversionCommon Stock 9,375 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007804 · doc4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,197.4877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
Scalet J ChrisExe V-P Global Srvs & CIO
Exercise / conversionRestricted Stock Unit · Derivative 9,750 $32.19 $313,852.50
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,750 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
Scalet J ChrisExe V-P Global Srvs & CIO
Tax withholdingCommon Stock 3,545 $32.19 $114,113.55
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 2

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,590.592

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
Scalet J ChrisExe V-P Global Srvs & CIO
Exercise / conversionCommon Stock 9,750 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,135.592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
KIM PETER SExe V-P & Pres, MRL
Exercise / conversionRestricted Stock Unit · Derivative 21,600 $32.19 $695,304.00
Disclosure

SEC source: 0001225208-11-007806 · doc4.xml · derivative · entry 4

KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,600 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
KIM PETER SExe V-P & Pres, MRL
Tax withholdingCommon Stock 8,530 $32.19 $274,580.70
Disclosure

SEC source: 0001225208-11-007806 · doc4.xml · nonDerivative · entry 2

KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,004.9037

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC
KIM PETER SExe V-P & Pres, MRL
Exercise / conversionCommon Stock 21,600 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007806 · doc4.xml · nonDerivative · entry 1

KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,534.9037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:09 UTC
KELLOGG PETER NExe V-P & CFO
Exercise / conversionRestricted Stock Unit · Derivative 11,700 $32.19 $376,623.00
Disclosure

SEC source: 0001225208-11-007808 · doc4.xml · derivative · entry 3

KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,700 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:09 UTC
KELLOGG PETER NExe V-P & CFO
Tax withholdingCommon Stock 4,253 $32.19 $136,904.07
Disclosure

SEC source: 0001225208-11-007808 · doc4.xml · nonDerivative · entry 2

KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,198.9013

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:09 UTC
KELLOGG PETER NExe V-P & CFO
Exercise / conversionCommon Stock 11,700 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007808 · doc4.xml · nonDerivative · entry 1

KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,451.9013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Deese Willie AExe V-P & Pres. MMD
Exercise / conversionRestricted Stock Unit · Derivative 11,700 $32.19 $376,623.00
Disclosure

SEC source: 0001225208-11-007810 · doc4.xml · derivative · entry 4

Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,700 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Deese Willie AExe V-P & Pres. MMD
Tax withholdingCommon Stock 3,454 $32.19 $111,184.26
Disclosure

SEC source: 0001225208-11-007810 · doc4.xml · nonDerivative · entry 2

Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,743.41

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Deese Willie AExe V-P & Pres. MMD
Exercise / conversionCommon Stock 11,700 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007810 · doc4.xml · nonDerivative · entry 1

Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,197.41

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Canan JohnSr.V-P Finc-Global Controller
Exercise / conversionRestricted Stock Unit · Derivative 4,950 $32.19 $159,340.50
Disclosure

SEC source: 0001225208-11-007812 · doc4.xml · derivative · entry 4

Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,950 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Canan JohnSr.V-P Finc-Global Controller
Tax withholdingCommon Stock 1,800 $32.19 $57,942.00
Disclosure

SEC source: 0001225208-11-007812 · doc4.xml · nonDerivative · entry 2

Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,040.054

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Canan JohnSr.V-P Finc-Global Controller
Exercise / conversionCommon Stock 4,950 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007812 · doc4.xml · nonDerivative · entry 1

Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,840.054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Exercise / conversionRSU - Leader Shares · Derivative 6,000 $32.19 $193,140.00
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · derivative · entry 6

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Exercise / conversionRestricted Stock Unit · Derivative 11,700 $32.19 $376,623.00
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · derivative · entry 5

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,700 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Tax withholdingCommon Stock 4,253 $32.19 $136,904.07
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · nonDerivative · entry 4

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,748.7171

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Tax withholdingCommon Stock 2,312 $32.19 $74,423.28
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · nonDerivative · entry 3

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,001.7171

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Exercise / conversionCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · nonDerivative · entry 2

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,313.7171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
Exercise / conversionCommon Stock 11,700 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007814 · doc4.xml · nonDerivative · entry 1

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,313.7171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Exercise / conversionRSU - Leader Shares · Derivative 6,600 $32.19 $212,454.00
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · derivative · entry 6

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,600 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Exercise / conversionRestricted Stock Unit · Derivative 9,750 $32.19 $313,852.50
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · derivative · entry 5

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,750 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Tax withholdingCommon Stock 3,545 $32.19 $114,113.55
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · nonDerivative · entry 4

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,633.1697

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Tax withholdingCommon Stock 2,400 $32.19 $77,256.00
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · nonDerivative · entry 3

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,178.1697

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Exercise / conversionCommon Stock 6,600 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · nonDerivative · entry 2

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,578.1697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:10 UTC Exercise / conversionCommon Stock 9,750 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007815 · doc4.xml · nonDerivative · entry 1

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,978.1697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:00 UTC
Canan JohnSr.V-P Finc-Global Controller
GrantCommon Stock 3,761 $32.34 $121,630.74
Disclosure

SEC source: 0001225208-11-007020 · doc4.xml · nonDerivative · entry 1

Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,890.054

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:01 UTC
CLARK RICHARD TDirector · Chairman
GrantCommon Stock 71,016 $32.34 $2,296,657.44
Disclosure

SEC source: 0001225208-11-007021 · doc4.xml · nonDerivative · entry 1

CLARK RICHARD T · CIK 0001181282 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,016

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:01 UTC
Deese Willie AExe V-P & Pres. MMD
GrantCommon Stock 9,996 $32.34 $323,270.64
Disclosure

SEC source: 0001225208-11-007022 · doc4.xml · nonDerivative · entry 1

Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,497.41

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:01 UTC
FRAZIER KENNETH CDirector · President & CEO
GrantCommon Stock 23,014 $32.34 $744,272.76
Disclosure

SEC source: 0001225208-11-007023 · doc4.xml · nonDerivative · entry 1

FRAZIER KENNETH C · CIK 0001181175 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,271.3462

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:01 UTC
KIM PETER SExe V-P & Pres, MRL
GrantCommon Stock 18,037 $32.34 $583,316.58
Disclosure

SEC source: 0001225208-11-007024 · doc4.xml · nonDerivative · entry 1

KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,934.9037

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:02 UTC
Scalet J ChrisExe V-P Global Srvs & CIO
GrantCommon Stock 7,511 $32.34 $242,905.74
Disclosure

SEC source: 0001225208-11-007025 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,385.592

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:02 UTC
Turner MervynChief Strategy Officer
GrantCommon Stock 3,541 $32.34 $114,515.94
Disclosure

SEC source: 0001225208-11-007026 · doc4.xml · nonDerivative · entry 1

Turner Mervyn · CIK 0001475383 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,464.7647

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:02 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
GrantCommon Stock 652 $32.34 $21,085.68
Disclosure

SEC source: 0001225208-11-007027 · doc4.xml · nonDerivative · entry 1

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,435

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:02 UTC GrantCommon Stock 7,509 $32.34 $242,841.06
Disclosure

SEC source: 0001225208-11-007028 · doc4.xml · nonDerivative · entry 1

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,228.1697

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:03 UTC
KELLOGG PETER NExe V-P & CFO
GrantCommon Stock 9,083 $32.34 $293,744.22
Disclosure

SEC source: 0001225208-11-007029 · doc4.xml · nonDerivative · entry 1

KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,751.9013

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:03 UTC
Kuhlik Bruce NExe V-P & Gen Counsel
GrantCommon Stock 9,045 $32.34 $292,515.30
Disclosure

SEC source: 0001225208-11-007030 · doc4.xml · nonDerivative · entry 1

Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,613.7171

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:03 UTC
Schechter Adam HEVP & Pres-Global Human Health
GrantCommon Stock 7,796 $32.34 $252,122.64
Disclosure

SEC source: 0001225208-11-007031 · doc4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,822.4877

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 08, 2011 Filed Feb 9, 2011 18:47 UTC
CLARK RICHARD TDirector · Chairman
GrantRestricted Stock Unit · Derivative 180,343 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-005115 · doc4.xml · derivative · entry 3

CLARK RICHARD T · CIK 0001181282 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,343

Underlying: Common Stock · 180,343 shares

Expires 2014-02-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 01, 2011 Filed Feb 2, 2011 20:26 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,000 $33.17 $99,510.00
Disclosure

SEC source: 0001225208-11-004570 · doc4.xml · derivative · entry 3

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2011-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 01, 2011 Filed Feb 2, 2011 20:26 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Tax withholdingCommon Stock 1,217 $33.17 $40,367.89
Disclosure

SEC source: 0001225208-11-004570 · doc4.xml · nonDerivative · entry 2

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,783

Read SEC document
February 01, 2011 Filed Feb 2, 2011 20:26 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-004570 · doc4.xml · nonDerivative · entry 1

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:51 UTC GrantPhantom Stock · Derivative 343.3685 $36.04 $12,375.00
Disclosure

SEC source: 0001225208-11-000080 · doc4.xml · derivative · entry 2

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,134.4058

Underlying: Common Stock · 343.3685 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:51 UTC GrantPhantom Stock · Derivative 589.6226 $36.04 $21,250.00
Disclosure

SEC source: 0001225208-11-000081 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,296.3858

Underlying: Common Stock · 589.6226 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:51 UTC GrantPhantom Stock · Derivative 825.4717 $36.04 $29,750.00
Disclosure

SEC source: 0001225208-11-000082 · doc4.xml · derivative · entry 2

HARRISON WILLIAM B JR · CIK 0001179576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,823.8959

Underlying: Common Stock · 825.4717 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:51 UTC GrantPhantom Stock · Derivative 658.99 $36.04 $23,750.00
Disclosure

SEC source: 0001225208-11-000083 · doc4.xml · derivative · entry 3

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,419.7749

Underlying: Common Stock · 658.99 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:51 UTC GrantPhantom Stock · Derivative 548.0022 $36.04 $19,750.00
Disclosure

SEC source: 0001225208-11-000084 · doc4.xml · derivative · entry 4

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,763.334

Underlying: Common Stock · 548.0022 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 31, 2010 Filed Jan 3, 2011 17:52 UTC GrantPhantom Stock · Derivative 617.3696 $36.04 $22,250.00
Disclosure

SEC source: 0001225208-11-000085 · doc4.xml · derivative · entry 3

REPRESAS CARLOS E · CIK 0001216083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,376.0811

Underlying: Common Stock · 617.3696 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.